Intragenic CAMTA1 deletions are associated with a spectrum of neurobehavioral phenotypes
- 20 May 2014
- journal article
- case report
- Published by Wiley in Clinical Genetics
- Vol. 87 (5), 478-482
- https://doi.org/10.1111/cge.12407
Abstract
Intragenic copy number variations involving the CAMTA1 (calmodulin-binding transcription activator 1) gene have recently been reported in four unrelated families with intellectual disability (ID), ataxia, behavioral- and cerebellar-abnormalities. We report a detailed phenotypic and molecular characterization of three individuals with novel intragenic CAMTA1 deletions from two unrelated families and compare the findings to those of previously reported patients. Our patients had deletions of exons 6-11 and presented with ID, developmental delay (DD), attention deficit hyperactivity disorder (ADHD) and constipation. Two individuals from one family had also unsteady gait. Consistent phenotypes associated with CAMTA1 intragenic rearrangements include ID, speech problems and some dysmorphic features whereas neurobehavioral abnormalities are variable. We did not observe obvious phenotypic differences between patients with in-frame and those with frameshift rearrangements. There is an increased evidence that CAMTA1 has a role in brain and cerebellar function. CAMTA1 should be added to the growing list of genes associated with ID/DD, especially when behavioral problems, cerebellar signs, and/or dysmorphism are also present.Keywords
This publication has 8 references indexed in Scilit:
- IntragenicCAMTA1rearrangements cause non-progressive congenital ataxia with or without intellectual disabilityJournal of Medical Genetics, 2012
- Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disordersAmerican Journal of Medical Genetics Part A, 2011
- CAMTA1, a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma CellsCancer Research, 2011
- Functional impact of global rare copy number variation in autism spectrum disordersNature, 2010
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesAmerican Journal of Human Genetics, 2010
- The array CGH and its clinical applicationsDrug Discovery Today, 2008
- Calmodulin-binding transcription activator 1 ( CAMTA1 ) alleles predispose human episodic memory performanceHuman Molecular Genetics, 2007
- Scale for the assessment and rating of ataxiaNeurology, 2006